2Rosenstock J,Schwartz SL,Clark C,et al.Basal insulin therapy in type 2 diabetes:27-week comparison of insulin glargine (HOM9OI) and NPH insulin[J].Diabetes Care,2001,24(11):631-636.
3Houlden R,Harris S,Yale JF,et al.Treatment satisfaction and quality of life with an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of type 2 diabetes:the Canadian insight study[J].Value Health,2005,8:A172.
4Klonoff DC.Continuous glucose monitoring:roadmap for 21st century diabetes therapy[J].Diabetes Care,2005,28(5):1231-1239.
8Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med,2010,362 : 1090-1101.
9Dunn CJ Plosker GL, Keating GM,et al. Insulin glargine:an up-dated re- view of its use in the management of diabetes mellitus. Drugs,2003,63: 1743-1748.
10Enc FY, Imerylyuz N, Akin L, et al. Inhibition of gastricemptying by acar- bose is correlated with GLP-1 response and accompanied by CCK release. Am J Physial,2001,281:752-763.
